Optimal Control Model of Tumor Treatment with Oncolytic Virus and MEK Inhibitor
Tumors are a serious threat to human health. The oncolytic virus is a kind of tumor killer virus which can infect and lyse cancer cells and spread through the tumor, while leaving normal cells largely unharmed. Mathematical models can help us to understand the tumor-virus dynamics and find better tr...
Main Authors: | , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2016-01-01
|
Series: | BioMed Research International |
Online Access: | http://dx.doi.org/10.1155/2016/5621313 |
id |
doaj-a0c27504f6a1442f9c8ff803e6dbf5c8 |
---|---|
record_format |
Article |
spelling |
doaj-a0c27504f6a1442f9c8ff803e6dbf5c82020-11-24T20:55:22ZengHindawi LimitedBioMed Research International2314-61332314-61412016-01-01201610.1155/2016/56213135621313Optimal Control Model of Tumor Treatment with Oncolytic Virus and MEK InhibitorYongmei Su0Chen Jia1Ying Chen2School of Mathematics and Physics, University of Science and Technology Beijing, Beijing, ChinaSchool of Mathematics and Physics, University of Science and Technology Beijing, Beijing, ChinaSchool of Mathematics and Physics, University of Science and Technology Beijing, Beijing, ChinaTumors are a serious threat to human health. The oncolytic virus is a kind of tumor killer virus which can infect and lyse cancer cells and spread through the tumor, while leaving normal cells largely unharmed. Mathematical models can help us to understand the tumor-virus dynamics and find better treatment strategies. This paper gives a new mathematical model of tumor therapy with oncolytic virus and MEK inhibitor. Stable analysis was given. Because mitogen-activated protein kinase (MEK) can not only lead to greater oncolytic virus infection into cancer cells, but also limit the replication of the virus, in order to provide the best dosage of MEK inhibitors and balance the positive and negative effect of the inhibitors, we put forward an optimal control problem of the inhibitor. The optimal strategies are given by theory and simulation.http://dx.doi.org/10.1155/2016/5621313 |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Yongmei Su Chen Jia Ying Chen |
spellingShingle |
Yongmei Su Chen Jia Ying Chen Optimal Control Model of Tumor Treatment with Oncolytic Virus and MEK Inhibitor BioMed Research International |
author_facet |
Yongmei Su Chen Jia Ying Chen |
author_sort |
Yongmei Su |
title |
Optimal Control Model of Tumor Treatment with Oncolytic Virus and MEK Inhibitor |
title_short |
Optimal Control Model of Tumor Treatment with Oncolytic Virus and MEK Inhibitor |
title_full |
Optimal Control Model of Tumor Treatment with Oncolytic Virus and MEK Inhibitor |
title_fullStr |
Optimal Control Model of Tumor Treatment with Oncolytic Virus and MEK Inhibitor |
title_full_unstemmed |
Optimal Control Model of Tumor Treatment with Oncolytic Virus and MEK Inhibitor |
title_sort |
optimal control model of tumor treatment with oncolytic virus and mek inhibitor |
publisher |
Hindawi Limited |
series |
BioMed Research International |
issn |
2314-6133 2314-6141 |
publishDate |
2016-01-01 |
description |
Tumors are a serious threat to human health. The oncolytic virus is a kind of tumor killer virus which can infect and lyse cancer cells and spread through the tumor, while leaving normal cells largely unharmed. Mathematical models can help us to understand the tumor-virus dynamics and find better treatment strategies. This paper gives a new mathematical model of tumor therapy with oncolytic virus and MEK inhibitor. Stable analysis was given. Because mitogen-activated protein kinase (MEK) can not only lead to greater oncolytic virus infection into cancer cells, but also limit the replication of the virus, in order to provide the best dosage of MEK inhibitors and balance the positive and negative effect of the inhibitors, we put forward an optimal control problem of the inhibitor. The optimal strategies are given by theory and simulation. |
url |
http://dx.doi.org/10.1155/2016/5621313 |
work_keys_str_mv |
AT yongmeisu optimalcontrolmodeloftumortreatmentwithoncolyticvirusandmekinhibitor AT chenjia optimalcontrolmodeloftumortreatmentwithoncolyticvirusandmekinhibitor AT yingchen optimalcontrolmodeloftumortreatmentwithoncolyticvirusandmekinhibitor |
_version_ |
1716791549613834240 |